MedPath

Intrawound Administration of Vancomycin in TKA

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Procedure: Intrawound administration of vancomycin after closure of the arthrotomy
Registration Number
NCT05338021
Lead Sponsor
The Affiliated Hospital of Qingdao University
Brief Summary

The purpose of this study is to determine the intra-articular and serum levels of vancomycin over the first 24 hours postoperatively after intra-articular administration of a standard dose of vancomycin in primary total knee arthroplasty.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Age between 50 and 80
  2. Total knee arthroplasty for primary osteoarthritis. Primary diagnosis of knee osteoarthritis
Read More
Exclusion Criteria
  1. Diminished mental capacity
  2. Vancomycin allergy
  3. Chronic kidney disease stage III and stage IV
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intrawound Administration of VancomycinIntrawound administration of vancomycin after closure of the arthrotomyAfter closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 20ml of normal saline was injected directly into the joint.
Intrawound Administration of Vancomycin combined with epsilon-aminocaproic acid (EACA)Intrawound administration of vancomycin after closure of the arthrotomyAfter closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 4g (20ml) of epsilon-aminocaproic acid (EACA) was injected directly into the joint.
Primary Outcome Measures
NameTimeMethod
Intra-articular vancomycin concentration2 hours, 8 hours and 24 hours postoperatively
Serum vancomycin concentration2 hours, 8 hours and 24 hours postoperatively
Renal functionPostoperative Day 1 and Day 3

blood urea nitrogen (BUN), creatinine (Cr), GFR

Blood lossPostoperative Day 3
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The affiliated hospital of Qingdao University

🇨🇳

Qingdao, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath